Latest news
Iconovo develops new formulations to strengthen the product portfolio (only in Swedish)
Breddat erbjudande med egen utveckling.
Iconovo AB (publ) utökar erbjudandet med egenutvecklade läkemedelsformuleringar för bolagets inhalatorer. Ett…
Iconovo at CPhI in Madrid
Iconovo attended CPhI in Madrid last week which marked the start of our new collaboration with Stevanato Group and ICOcap. Truly an exiting moment and…
Press releases
Dec 21, 2020, 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Dec 21, 2020, 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Nov 26, 2020, 14:38
News
IR
Swedish
Corporate Information
Other Corporate Information
Nov 26, 2020, 14:38
News
IR
English
Corporate Information
Other Corporate Information
Nov 17, 2020, 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 17, 2020, 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Oct 28, 2020, 08:33
News
IR
English
Corporate Information
Other Corporate Information
Oct 27, 2020, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Oct 19, 2020, 13:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Oct 19, 2020, 13:30
News
IR
English
Corporate Information
Other Corporate Information
Sep 30, 2020, 09:00
News
IR
English
Corporate Information
Presentation
Sep 30, 2020, 09:00
News
IR
Swedish
Corporate Information
Presentation
Sep 15, 2020, 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Sep 02, 2020, 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 20, 2020, 13:51
News
IR
English
Corporate Information
Other Corporate Information
Aug 20, 2020, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Aug 20, 2020, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 19, 2020, 09:30
News
IR
English
Corporate Information
Other Corporate Information
Aug 19, 2020, 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 19, 2020, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
